Business
Press Release Nov 12 2020
Cadila Healthcare Limited has informed the Exchange regarding a press release dated November 12, 2020, titled "Zydus successfully completes Phase II clinical trials with Pegylated Interferon alpha-2b in India; the Company to start Phase III clinical trials".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Cadila Healthcare Limited has informed the Exchange regarding a press release dated November 12, 2020, titled \"Zydus successfully completes Phase II clinical trials with Pegylated Interferon alpha-2b in India; the Company to start Phase III clinical trials\". View Attachment","length":411,"tagName":"div"}]